Filters
Hikma reiterates full year 2026 guidance following encouraging start to the year
Press Release, Financial Results
New
Putting patients first through quality: a Q&A with Tyson Ardo, Associate Vice President, Quality
Story, Life at Hikma
Inside Injectables: A Q&A with Natheer Masarweh, SVP of Injectables Operations | Manufacturing Today
Insight, Product
Investing in R&D to drive high-value pipeline delivery
Insight, Report Case Study
Investing in manufacturing excellence at Hikma
Insight, Report Case Study
Investing in MENA to expand access and drive growth
Insight, Report Case Study
Investing in strategic partnerships driving growth in the US and MENA
Insight, Report Case Study
Investing in the development of our people for long‑term growth
Insight, Report Case Study
Hikma launches authorised generic of Nucynta® ER (tapentadol) extended-release in the US
Press Release, Product
Hikma R&D. Innovation in formulation development. Meet Hamza Qassim
Story, Life at Hikma
Hikma delivers Group revenue and profit growth and announces share buyback and leadership changes
Press Release, Financial Results
Hikma launches authorised generic of Nucynta® (tapentadol) in the US
Press Release, Product
New
Inspired at Hikma. Meet Ana Santos Perez
Story, Life at Hikma
Hikma R&D. Innovation in clinical research. Meet Hiba Kamal
Story, Life at Hikma